EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum FT3/FT4 ratio may indicate the degree of T3 compensation in congenital hypothyroidism

Takeru Yamauchi iD, Ami Keidai, Yutaro Tomobe, Seiichi Tomotaki, Kougoro Iwanaga, Junko Takita, Masahiko Kawai

PLOS One · 11.11.2026 · 21 (11) · e0361192

DOI: 10.1371/journal.pone.0361192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 11.11.2026. Verfasst von Takeru Yamauchi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Congenital Hypothyroidism, Thyroxine, Triiodothyronine. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clinical guidelines for hypothyroidism recommend measuring serum thyroid-stimulating hormone (TSH) and free thyroxine (FT4) levels as diagnostic and treatment efficacy indicators. However, they do not recommend measuring serum free triiodothyronine (FT3) levels because serum FT3 levels often remain within the normal range. However, serum TSH and FT4 levels alone make diagnosis and treatment decision-making difficult in conditions such as central hypothyroidism, suggesting the need for an additional indicator distinct from serum TSH levels. We investigated whether the serum FT3/FT4 ratio could be an indicator of congenital hypothyroidism (CH) severity, instead of serum TSH level.

Methods

Thirty-seven newborns were diagnosed with CH (severe group (n = 13): serum TSH ≥ 30 mIU/L; moderate group (n = 24): serum TSH ≥ 5 to < 30 mIU/L). All infants in the severe group received thyroid hormone (TH) replacement therapy vs 13 infants in the moderate group (moderate group with CH). Serum TSH, FT4, FT3, and FT3/FT4 ratios were compared between each group and the two control groups of different ages at diagnosis and 2 months after treatment.

Results

The serum FT3/FT4 ratio was elevated before treatment compared with the control group, reflecting CH severity. Two months after TH replacement, the serum FT3/FT4 ratio decreased significantly: severe group: at diagnosis, 0.48 vs 2 months, 0.27, p =

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Congenital HypothyroidismThyroxineTriiodothyronineHumansThyrotropinInfant, NewbornMaleFemaleHormone Replacement Therapy

Substanzen

ThyroxineTriiodothyronineThyrotropin

Autor:innen und Institutionen

  • Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

ORCID-Profile: Takeru Yamauchi

Zitieren

APA

Yamauchi, T., Keidai, A., Tomobe, Y., Tomotaki, S., Iwanaga, K., Takita, J., & Kawai, M. (2026). Serum FT3/FT4 ratio may indicate the degree of T3 compensation in congenital hypothyroidism. PLOS One, 21(11), e0361192. https://doi.org/10.1371/journal.pone.0361192

Vancouver

Yamauchi T, Keidai A, Tomobe Y, Tomotaki S, Iwanaga K, Takita J, et al. Serum FT3/FT4 ratio may indicate the degree of T3 compensation in congenital hypothyroidism. PLOS One. 2026;21(11):e0361192. doi:10.1371/journal.pone.0361192

BibTeX
@article{Yamauchi2026,
  author = {Yamauchi, Takeru and Keidai, Ami and Tomobe, Yutaro and Tomotaki, Seiichi and Iwanaga, Kougoro and Takita, Junko and Kawai, Masahiko},
  title = {Serum FT3/FT4 ratio may indicate the degree of T3 compensation in congenital hypothyroidism},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {11},
  pages = {e0361192},
  doi = {10.1371/journal.pone.0361192}
}
Kostenlos starten →